Quantcast
Press "Enter" to skip to content

Pfizer CEO claims boosters may be lifelong hinting at Pharma ‘s financial hopes of the future

Pfizer ‘s outspoken CEO Albert Bourla has spent his weekend talking up boosters and the importance of vaccinations. Though according to new reports and publicly made comments, Pfizer is trying to ensure that their own financial stability remains profitable and that would be made possible by lifelong booster shots.

Editors note: We’d like to remind people that although we may be critical of “Big Pharma” we are in no way anti-vax. However, we do find that people profiting off of a natural disaster and the desperate attempts to stay alive by other people as morally and institutionally foul.

Last week government officials in America affirmed that the company’s booster shots can be used in people who are elderly or are at higher risk for the virus (or due to their job.) Those approvals are expected to help the company net more than $26B in profits come this time roughly next year.

Pfizer’s stock price has risen from $30.99 pre-pandemic to $43.94 today.

Marketwatch has more financial information on the stock rises amid public perception that the medical industry is profiting off of a natural disaster.

Be First to Comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Verified by MonsterInsights